Rol' otdel'nykh faktorov v profilaktike prezhdevremennykh rodov
- Authors: Solov'eva A.V1, Khapova T.V1, Kuznetsova O.A1, Olenev A.S1
-
Affiliations:
- Issue: No 12 (2013)
- Pages: 71-73
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/282272
- ID: 282272
Cite item
Open Access
Access granted
Abstract
The article discusses the factors of risk of premature delivery, including the important role of disruption of the normal vaginal biocenosis. The results of evaluation of long-term outcomes of mono- and two-stage treatment of vaginosis and vaginitis in 84 women of reproductive age are presented. After a course of anti-infective therapy, one group of women received drug for vaginal use with ascorbic acid as a drug for restoration of vaginal microbiota, that contributed to effective prevention of recurrence of inflammatory diseases of the vagina.
Full Text
About the authors
A. V Solov'eva
Email: av_soloveva@mail.ru
T. V Khapova
O. A Kuznetsova
A. S Olenev
References
- Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002 360:1489-97.
- Jakobsson M, Gissler M, Sainio S, et al. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet and Gynecol 2007;109:309-13. PMID: 17267829.
- Krupa FG, Faltin D, Cecatti JG, et al. Predictors of preterm birth. Int J Gynaecol Obstet 2006;94(1):11. PMID: 16730012.
- Колесниченко Л.C., Куперт А.Ф., Ульфан Т.Н., Станевич Л.М., Губина Л.П. Антиоксидантный статус плаценты при осложненной беременности / Материалы II Российского форума "Мать и дитя". Сб. научн. трудов. М., 2000. 62 с.
- Бабакова Л.А. Формирование здоровья новорожденных и детей первого года жизни, родившихся в условиях невынашивания беременности (патогенез, прогноз, диагностика, профилактика нарушений): Дисс. канд. мед. наук. Иваново, 1997. 23 с.
- Koutsky LA, Stamm WE, Brunham RC, Stevens CE, Cole B, Hale J, et al. Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. Sex Transm Dis 1983;(Suppl. 4):374-81.
Supplementary files
